thalidomide has been researched along with Deglutition Disorders in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Deglutition Disorders: Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lenalidomide was confirmed to remain stable in hot water at 55℃ for 24 h in the prepared suspension by the simple suspension method, and more than 99% of the drug could be recovered from the suspension." | 1.43 | Stability of lenalidomide suspension after preparation by a simple suspension method for enteral tube administration. ( Endo, K; Fujii, H; Izumi, K; Kimura, S; Minami, H; Morita, TO; Saito, S; Yamaguchi, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R | 1 |
| Liu, X | 1 |
| Hao, J | 1 |
| Barkin, JA | 1 |
| Schonfeld, WB | 1 |
| Deshpande, AR | 1 |
| Morita, TO | 1 |
| Yamaguchi, A | 1 |
| Kimura, S | 1 |
| Fujii, H | 1 |
| Endo, K | 1 |
| Izumi, K | 1 |
| Saito, S | 1 |
| Minami, H | 1 |
3 other studies available for thalidomide and Deglutition Disorders
| Article | Year |
|---|---|
Esophageal Sinus in a Patient With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Cyclophosphamide; Deglutition Diso | 2020 |
Successful use of thalidomide for refractory esophageal Crohn's disease.
Topics: Crohn Disease; Deglutition Disorders; Enteral Nutrition; Esophagitis; Esophagoscopy; Female; Gastros | 2013 |
Stability of lenalidomide suspension after preparation by a simple suspension method for enteral tube administration.
Topics: Adsorption; Angiogenesis Inhibitors; Chromatography, High Pressure Liquid; Deglutition Disorders; Dr | 2016 |